TrialSignal transduction and targeted therapy2024

Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial.

Jinyuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.